Eylea 2 MG/0.05 ML syringe 0.05ML
Ended Awarded
- Contract number
- SPE2DX25F6AHA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $24,446
Award facts
- Contract value 100% obligated
- $24,446.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $24,446 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on September 23, 2025, for the supply of EYLEA 2 mg/0.05 ml syringes. The contract, which carries no set-aside designation, is scheduled for completion by October 15, 2025, with performance taking place at the contractor's Park Ridge facility. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026, which authorizes the issuance of firm fixed-price orders for comprehensive pharmaceutical products supporting Department of Defense healthcare facilities.
EYLEA is a vascular endothelial growth factor inhibitor used primarily for the treatment of age-related macular degeneration and other retinal conditions. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its established relationship with the Defense Logistics Agency to deliver specialized pharmaceutical products directly to military health facilities nationwide. The company's robust contract portfolio demonstrates consistent success in federal procurement markets, with this award reflecting its capability to provide timely delivery of high-value pharmaceutical products essential to military healthcare operations.
Quick answers
Who was awarded contract SPE2DX25F6AHA?
SPE2DX25F6AHA was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 23, 2025.
How much is contract SPE2DX25F6AHA worth?
The government has obligated $24,446 on SPE2DX25F6AHA.
Is contract SPE2DX25F6AHA an order under another contract?
Yes. SPE2DX25F6AHA is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AHA competed?
The extent of competition for SPE2DX25F6AHA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award